✦ LIBER ✦

Pharmacoeconomics of Cancer Therapies: Considerations With the Introduction of Biosimilars

✍ Scribed by Henry, David; Taylor, Carrie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacoeconomic Analysis Of Docetaxel I

✍ Zinchuk, I.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PHARMACOECONOMIC CONSIDERATIONS IN THE T

✍ Sabai, M.; Mulchahey, J.J.; Malik, M.; Kasckow, J.W. 📂 Article 📅 1999 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 58 KB

Nonclinical Development of Novel Biologi

✍ Nasis, Rania 📂 Article 📅 2013 🏛 Elsevier ⚖ 422 KB

PCN97 Pharmacoeconomic Analysis of the P

✍ V. Omelyanovsky; M. Avxentyeva; O. Ivakhnenko; P. Khailov; I. Krysanov; L. Maksi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Dosimetric considerations in radiation t

✍ Mary Louise Meurk 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Considerations for the successful co-dev

✍ Fridlyand, Jane; Simon, Richard M.; Walrath, Jessica C.; Roach, Nancy; Buller, R 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 493 KB